Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification

Matsuo, Koji; Klar, Maximilian; Khetan, Varun; Vallejo, Andrew; Violette, Caroline; Tavakoli, Amin; Nusbaum, David J.; Roman, Lynda D.; Wright, Jason D.

doi:10.1016/j.ygyno.2022.02.023

Cited by 4 publications

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, real-world incorporation of SLN biopsy appears to cover a wider population than expected. A population-based retrospective study by Matsuo et al [ 33 , 34 ] showed that clinicians have begun to perform SLN biopsy in stage II and T3 diseases, which is beyond the current guideline recommendations. We speculated that clinicians have begun to universally adopt SLN biopsy in the absence of distant metastases.…”

Section: Resultsmentioning

confidence: 99%

Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues

Kim

2022

Obstet Gynecol Sci

View full text Add to dashboard Cite

Endometrial cancer is the second most common gynecological malignancy worldwide, with an overall favorable prognosis. However, a subgroup of patients has a high risk of recurrence and poor prognosis. This review summarizes recently published articles that examined sentinel lymph node (SLN) biopsy in patients with high-risk endometrial cancer. We focused on the performance and outcomes of SLN biopsy, and examined potential methods for improving the management of this high-risk subset. Few studies have examined the long-term outcomes of SLN in patients with high-risk endometrial cancer.Thus, we reviewed recently published retrospective studies that have adopted statistical techniques, such as inverse probability weighting or propensity score matching, to examine the outcome of SLN biopsy compared to conventional lymphadenectomy. Potential avenues for future research to fine-tune decision making for this patient subgroup were also discussed.

show abstract

Section: Resultsmentioning

confidence: 99%

Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues

Kim

2022

Obstet Gynecol Sci

View full text Add to dashboard Cite

show abstract

“…Italy SLN 40 5-yr overall survival rate 6 LND 42 Dimitrios Nasioudis, 2021 [15] 2012-2015 2022 [16] 2010-2018…”

Section: Multicentermentioning

confidence: 99%

Impact of sentinel lymph node assessment on the outcomes of patients with advanced endometrial cancer: A meta-analysis

et al. 2023

View full text Add to dashboard Cite

Background: Sentinel lymph node (SLN) assessment is used to treat early endometrial cancer; however, its application in advanced endometrial cancer remains controversial. Therefore, we assessed the effects of SLN assessment and lymphadenectomy (LND) on the prognosis (survival rate and primary outcome) of patients with advanced endometrial cancer. Methods: Pertinent studies were selected from PubMed, Embase, Web of Science, and the Cochrane Library until March 19, 2022. Relevant studies were strictly screened according to the inclusion and exclusion criteria. Data from the included studies were extracted and their quality was evaluated. Then RevMan5.4 software was used for the meta-analysis. Results: Four retrospective studies were included, which enrolled 7181 patients; 492 were treated with SLN and 6689 with LND. In terms of overall survival, there was no significant difference between the 2 groups (odds ratio = 1.14, 95% confidence interval: 0.92–1.41, I 2 = 0%, P = .39). Conclusions: SLN assessment is an alternative to LND as a treatment modality for advanced endometrial cancer.

show abstract

Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery

Matsuo

Klar

Barakzai

et al. 2022

Arch Gynecol Obstet

View full text Add to dashboard Cite

Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification

Cited by 4 publications

References 26 publications

Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues

Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues

Impact of sentinel lymph node assessment on the outcomes of patients with advanced endometrial cancer: A meta-analysis

Utilization of sentinel lymph node biopsy in the early ovarian cancer surgery

Contact Info

Product

Resources

About